13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001799883-26-000001
Total Value
$318.1M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ENTRADA THERAPEUTICS INC | TRDA | 4,056,379 | $41.7M | 13.11% |
| 2 | CAMP4 THERAPEUTICS CORP | CAMP | 5,869,091 | $36.0M | 11.31% |
| 3 | TYRA BIOSCIENCES INC | TYRA | 1,029,298 | $27.1M | 8.51% |
| 4 | VIRIDIAN THERAPEUTICS INC | VRDN | 736,595 | $22.9M | 7.21% |
| 5 | PHARVARIS N V | PHVS | 797,600 | $22.1M | 6.96% |
| 6 | ERASCA INC | ERAS | 5,405,404 | $20.1M | 6.32% |
| 7 | EYEPOINT INC | EYPT | 1,050,000 | $19.2M | 6.03% |
| 8 | MAPLIGHT THERAPEUTICS INC | MPLT | 950,011 | $16.7M | 5.25% |
| 9 | CENTESSA PHARMACEUTICALS PLC | CNTA | 580,945 | $14.5M | 4.57% |
| 10 | CELLDEX THERAPEUTICS INC NEW | CLDX | 497,270 | $13.5M | 4.25% |
| 11 | TECTONIC THERAPEUTIC INC | TECX | 606,660 | $12.7M | 3.98% |
| 12 | ENLIVEN THERAPEUTICS INC | ELVN | 772,477 | $11.9M | 3.74% |
| 13 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 2,353,304 | $10.1M | 3.17% |
| 14 | SURROZEN INC | SRZNW | 387,500 | $8.8M | 2.75% |
| 15 | BIOHAVEN LTD | BHVN | 738,972 | $8.3M | 2.62% |
| 16 | PROTARA THERAPEUTICS INC | TARA | 1,369,782 | $7.3M | 2.30% |
| 17 | GH RESEARCH PLC | GHRS | 572,665 | $7.3M | 2.29% |
| 18 | SKYE BIOSCIENCE INC | SKYE | 9,681,763 | $7.3M | 2.28% |
| 19 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 3,947,913 | $5.3M | 1.68% |
| 20 | SILENCE THERAPEUTICS PLC | SLNCF | 476,200 | $2.9M | 0.91% |
| 21 | RALLYBIO CORP | RLYB | 3,630,724 | $2.5M | 0.78% |